Summus Global has filed a notice of an exempt offering of securities to raise $12 Million in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Summus Global is raising up to $12,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Summus Global
Summus quickly connects families with high-quality doctors to answer any health question, big or small. Using an innovative clinical navigation and specialty care model, we simplify the healthcare landscape and serve as a trusted guide to our members across any health journey. Summus has attracted the worlds best physicians across 120+ specialties and puts doctors the most trusted party in healthcare at the center of all health journeys, driving better, more cost-efficient health outcomes for families and employers. Our end-to-end programs support our members in cancer, musculoskeletal, womens health, and cardiometabolic health. With Summus, you get better access, better decisions, and better outcomes.
To learn more about Summus Global, visit https://www.summusglobal.com/
Summus Global Linkedin Page: https://www.linkedin.com/company/summus-inc./
Contact:
Julian Flannery, Chief Executive Officer
917-565-8540
https://www.linkedin.com/in/julian-flannery-0423/
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.
